Why Agios Pharmaceuticals Stock Is Soaring Today

Shares of Agios Pharmaceuticals (NASDAQ: AGIO) were soaring 22% as of 11:13 a.m. EST on Monday. The big gain came after the company announced that it plans to sell its oncology portfolio to Servier for $1.8 billion in cash upfront.

Agios will also be eligible to receive $200 million in milestone payments in the future for experimental brain cancer drug vorasidenib. In addition, the company will receive royalties on U.S. sales of acute myeloid leukemia drug Tibsovo and vorasidenib.

Investors obviously liked Agios' decision to sell off its oncology portfolio. There are three main reasons why.

Continue reading

Source Fool.com